Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients

被引:105
作者
Fauchier, T. [1 ]
Hasseine, L. [1 ]
Gari-Toussaint, M. [1 ]
Casanova, V. [2 ]
Marty, P. M. [1 ,3 ,4 ]
Pomares, C. [1 ,3 ,4 ]
机构
[1] CHU Archet 2, Lab Parasitol Mycol, Nice, France
[2] CHU Nice, Hop Cimiez, Dept Med Informat, F-06202 Nice, France
[3] Fac Med Nice, INSERM, U1065, C3M,Toxines Microbiennes Relat Hote Pathogenes, U210, F-06034 Nice, France
[4] Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France
关键词
REAL-TIME PCR; INFANT-DEATH-SYNDROME; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; BRONCHOALVEOLAR LAVAGE FLUID; CARINII-PNEUMONIA; INFECTED PATIENTS; IMMUNOSUPPRESSIVE THERAPY; CLINICAL-SIGNIFICANCE; GENERAL-POPULATION; CONVENTIONAL PCR;
D O I
10.1128/JCM.03174-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pneumocystis jirovecii pneumonia (PCP) is an acute and life-threatening lung disease caused by the fungus Pneumocystis jirovecii. The presentation of PCP in HIV-positive patients is well-known and consists of a triad of dyspnea, fever, and cough, whereas the presentation of PCP in HIV-negative patients is atypical and consists of a sudden outbreak, O-2 desaturation, and a rapid lethal outcome without therapy. Despite the availability of direct and indirect identification methods, the diagnosis of PCP remains difficult. The cycle threshold (C-T) values obtained by quantitative PCR (qPCR) allow estimation of the fungal burden. The more elevated that the fungal burden is, the higher the probability that the diagnosis is pneumonia. The purposes of the present study were to evaluate the C-T values to differentiate colonization and pneumonia in a population of immunocompromised patients overall and patients stratified on the basis of their HIV infection status. Testing of bronchoalveolar lavage (BAL) fluid samples from the whole population of qPCR-positive patients showed a mean C-T value for patients with PCP of 28 (95% confidence interval [CI], 26 to 30) and a mean C-T value for colonized patients of 35 (95% CI, 34 to 36) (P < 10(-3)). For the subgroup of HIV-positive patients, we demonstrated that a C-T value below 27 excluded colonization and a C-T value above 30 excluded PCP with a specificity of 100% and a sensitivity of 80%, respectively. In the subgroup of HIV-negative patients, we demonstrated that a C-T value below 31 excluded colonization and a C-T value above 35 excluded PCP with a specificity of 80% and a sensitivity of 80%, respectively. Thus, qPCR of BAL fluid samples is an important tool for the differentiation of colonization and pneumonia in P. jirovecii-infected immunocompromised patients and patients stratified on the basis of HIV infection status with different C-T values.
引用
收藏
页码:1487 / 1495
页数:9
相关论文
共 71 条
[41]   Nosocomial Pneumocystis jirovecii infections [J].
Nevez, G. ;
Chabe, M. ;
Rabodonirina, M. ;
Virmaux, M. ;
Dei-Cas, E. ;
Hauser, P. M. ;
Totet, A. .
PARASITE, 2008, 15 (03) :359-365
[42]   Apparent absence of Pneumocystis jirovecii in healthy subjects [J].
Nevez, G ;
Magois, E ;
Duwat, H ;
Gouilleux, V ;
Jounieaux, V ;
Totet, A .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) :E99-E101
[43]   Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease [J].
Norris, Karen A. ;
Morris, Alison .
IMMUNOLOGIC RESEARCH, 2011, 50 (2-3) :175-180
[44]  
OGNIBENE FP, 1995, AM J RESP CRIT CARE, V151, P795
[45]   THE RISK OF PNEUMOCYSTIS-CARINII PNEUMONIA AMONG MEN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
PHAIR, J ;
MUNOZ, A ;
DETELS, R ;
KASLOW, R ;
RINALDO, C ;
SAAH, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :161-165
[46]   Pneumocystis Colonization Is Highly Prevalent in the Autopsied Lungs of the General Population [J].
Ponce, Carolina A. ;
Gallo, Myriam ;
Bustamante, Rebeca ;
Vargas, Sergio L. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (03) :347-353
[47]   Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era [J].
Pulvirenti, J ;
Herrera, P ;
Venkataraman, P ;
Ahmed, N .
AIDS PATIENT CARE AND STDS, 2003, 17 (06) :261-265
[48]   Polymerase chain reaction detection of Pneumocystis jiroveci:: evaluation of 9 assays [J].
Robberts, Frans J. L. ;
Liebowitz, Lynne D. ;
Chalkley, Lynda J. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 58 (04) :385-392
[49]   Diagnosis of Pneumocystis jirovecii Pneumonia in Immunocompromised Patients by Real-Time PCR: a 4-Year Prospective Study [J].
Robert-Gangneux, Florence ;
Belaz, Sorya ;
Revest, Matthieu ;
Tattevin, Pierre ;
Jouneau, Stephane ;
Decaux, Olivier ;
Chevrier, Sylviane ;
Le Tulzo, Yves ;
Gangneux, Jean-Pierre .
JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (09) :3370-3376
[50]   PNEUMOCYSTIS-CARINII PNEUMONIA WITHOUT ACQUIRED-IMMUNODEFICIENCY-SYNDROME - MORE PATIENTS, SAME RISK [J].
SEPKOWITZ, KA ;
BROWN, AE ;
ARMSTRONG, D .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (11) :1125-1128